Skip to content
10-Q

Quarterly Report

CEREBAIN BIOTECH CORP.

0001477932-17-002177

← back to feed
Filed
May 11, 2017 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2017 · May 10, 2017 7.76M sh
Shares Diluted Q3 2017 · Mar 31, 2017 7.61M sh
Shares Diluted Q3 2017 · Mar 31, 2017 7.42M sh
Shares Diluted Q3 2017 · Mar 31, 2016 6.38M sh
Shares Diluted Q3 2017 · Mar 31, 2016 5.61M sh
Stockholders Equity Q3 2017 · Mar 31, 2017 −$3.88M
Stockholders Equity Q3 2017 · Jun 30, 2016 −$3.04M
Current Liabilities Q3 2017 · Mar 31, 2017 $1.51M
Current Liabilities Q3 2017 · Jun 30, 2016 $1.09M
Total Liabilities Q3 2017 · Mar 31, 2017 $4.28M
Total Liabilities Q3 2017 · Jun 30, 2016 $3.54M
Current Assets Q3 2017 · Mar 31, 2017 $403.29K
Current Assets Q3 2017 · Jun 30, 2016 $495.94K
Total Assets Q3 2017 · Mar 31, 2017 $403.29K
Total Assets Q3 2017 · Jun 30, 2016 $495.94K
Operating Income Q3 2017 · Mar 31, 2017 −$524.58K
Operating Income Q3 2017 · Mar 31, 2017 −$1.54M
Operating Income restated Q3 2017 · Mar 31, 2016 −$424.81K
Operating Income restated Q3 2017 · Mar 31, 2016 −$1.31M
Operating Cash Flow Q3 2017 · Mar 31, 2016 −$393.61K
Cash And Equivalents Q3 2017 · Mar 31, 2016 $2.77K
Cash And Equivalents Q3 2017 · Jun 30, 2015 $486
Sga Expense Q3 2017 · Mar 31, 2016 $397.47K
Sga Expense Q3 2017 · Mar 31, 2016 $1.12M
Net Income Q3 2017 · Mar 31, 2016 −$495.48K
Net Income Q3 2017 · Mar 31, 2016 −$1.57M